ALPHA TEKNOVA, INC. Increase (Decrease) in Inventories
ALPHA TEKNOVA, INC. (TKNO) reported Increase (Decrease) in Inventories of $682.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-06
- ALPHA TEKNOVA, INC. increase (decrease) in inventories for the quarter ending 2026-06-30 was $449.00K, a 70.56% decline year-over-year.
- ALPHA TEKNOVA, INC. increase (decrease) in inventories for the quarter ending 2026-03-31 was $233.00K, a 11.48% increase year-over-year.
- ALPHA TEKNOVA, INC. increase (decrease) in inventories for the quarter ending 2025-12-31 was $598.00K.
- ALPHA TEKNOVA, INC. increase (decrease) in inventories for the quarter ending 2025-09-30 was $36.00K, a 38.46% increase year-over-year.
- ALPHA TEKNOVA, INC. increase (decrease) in inventories for fiscal 2025 was $2.37M.
- ALPHA TEKNOVA, INC. increase (decrease) in inventories for fiscal 2024 was -$244.00K.
- ALPHA TEKNOVA, INC. increase (decrease) in inventories for fiscal 2023 was -$330.00K, a 104.37% decline from fiscal 2022.
- ALPHA TEKNOVA, INC. increase (decrease) in inventories for fiscal 2022 was $7.55M, a 235.11% increase from fiscal 2021.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2026-06-30 | $449.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $682.00K 10-Q · filed 2026-08-06 | $1.28M derived: sum of 3 quarters · filed 2026-08-06 | $1.32M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $233.00K 10-Q · filed 2026-05-07 | $831.00K derived: sum of 2 quarters · filed 2026-05-07 | $867.00K derived: sum of 3 quarters · filed 2026-05-07 | $2.39M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $598.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $634.00K derived: sum of 2 quarters · filed 2026-03-02 | $2.16M derived: sum of 3 quarters · filed 2026-08-06 | $2.37M 10-K · filed 2026-03-02 |
| 2025-09-30 | $36.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $1.56M derived: sum of 2 quarters · filed 2026-08-06 | $1.77M 10-Q · filed 2025-11-07 | $1.21M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $1.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $1.73M 10-Q · filed 2026-08-06 | $1.18M derived: sum of 3 quarters · filed 2026-08-06 | $1.20M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $209.00K 10-Q · filed 2026-05-07 | -$350.00K derived: sum of 2 quarters · filed 2026-05-07 | -$324.00K derived: sum of 3 quarters · filed 2026-05-07 | $443.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$559.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$533.00K derived: sum of 2 quarters · filed 2026-03-02 | $234.00K derived: sum of 3 quarters · filed 2026-03-02 | -$244.00K 10-K · filed 2026-03-02 |
| 2024-09-30 | $26.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $793.00K derived: sum of 2 quarters · filed 2025-11-07 | $315.00K 10-Q · filed 2025-11-07 | $634.00K derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | $767.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $289.00K 10-Q · filed 2025-08-08 | $608.00K derived: sum of 3 quarters · filed 2025-08-08 | $155.00K derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | -$478.00K 10-Q · filed 2025-05-09 | -$159.00K derived: sum of 2 quarters · filed 2025-05-09 | -$612.00K derived: sum of 3 quarters · filed 2025-05-09 | -$568.00K derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $319.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | -$134.00K derived: sum of 2 quarters · filed 2025-03-07 | -$90.00K derived: sum of 3 quarters · filed 2025-03-07 | -$330.00K 10-K · filed 2025-03-07 |
| 2023-09-30 | -$453.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$409.00K derived: sum of 2 quarters · filed 2024-11-08 | -$649.00K 10-Q · filed 2024-11-08 | $1.79M derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $44.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$196.00K 10-Q · filed 2024-08-13 | $2.25M derived: sum of 3 quarters · filed 2024-08-13 | $4.85M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | -$240.00K 10-Q · filed 2024-05-13 | $2.20M derived: sum of 2 quarters · filed 2024-05-13 | $4.80M derived: sum of 3 quarters · filed 2024-05-13 | $6.28M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $2.44M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $5.04M derived: sum of 2 quarters · filed 2024-03-27 | $6.52M derived: sum of 3 quarters · filed 2024-03-27 | $7.55M 10-K · filed 2024-03-27 |
| 2022-09-30 | $2.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $4.08M derived: sum of 2 quarters · filed 2023-11-13 | $5.11M 10-Q · filed 2023-11-13 | $5.86M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $1.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $2.51M 10-Q · filed 2023-08-11 | $3.26M derived: sum of 3 quarters · filed 2023-08-11 | $3.76M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $1.03M 10-Q · filed 2023-05-11 | $1.78M derived: sum of 2 quarters · filed 2023-05-11 | $2.28M derived: sum of 3 quarters · filed 2023-05-11 | $3.58M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $756.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $1.26M derived: sum of 2 quarters · filed 2023-03-30 | $2.55M derived: sum of 3 quarters · filed 2023-03-30 | $2.25M 10-K · filed 2023-03-30 |
| 2021-09-30 | $500.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $1.79M derived: sum of 2 quarters · filed 2022-11-14 | $1.50M 10-Q · filed 2022-11-14 | $2.12M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $1.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $997.00K 10-Q · filed 2022-08-11 | $1.62M derived: sum of 3 quarters · filed 2022-08-11 | $1.46M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | -$295.00K 10-Q · filed 2022-05-12 | $332.00K derived: sum of 2 quarters · filed 2022-05-12 | $167.00K derived: sum of 3 quarters · filed 2022-05-12 | |
| 2020-12-31 | $627.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | $462.00K derived: sum of 2 quarters · filed 2022-03-18 | $987.00K 10-K · filed 2022-03-18 | |
| 2020-09-30 | -$165.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $360.00K 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | $525.00K 10-Q · filed 2021-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |